Advances in PET imaging of P-glycoprotein function at the blood-brain barrier
"While Ozempic is well covered in the U.S., let's not forget that there are some patients who pay out-of-pocket for this vital medicine," Dave Moore, executive vice president of Novo Nordisk's U.S
If you have a history of eating disorders, thyroid disease, diabetes, cardiovascular disease, or are pregnant or nursing, behavioral app enrollment requires provider clearance
In 2021, Novo Nordisk had a market capitalisation of $171 billion, whereas only three years later it is nearing $600 billion
The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy